Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	302,271	170,528	81,683	-	-
Market Cap Growth	92.16%	108.77%	-	-	-
Enterprise Value	346,051	209,922	130,128	-	-
Last Close Price	227.95	128.81	66.78	-	-
PE Ratio	777.05	956.95	-	-	-
PS Ratio	3.94	2.09	1.15	-	-
PB Ratio	4.46	2.15	1.21	-	-
P/TBV Ratio	9.46	4.71	3.51	-	-
P/FCF Ratio	58.30	-	-	-
P/OCF Ratio	16.98	16.88	-	-
EV/Sales Ratio	3.87	2.57	1.84	-	-
EV/EBITDA Ratio	23.42	18.43	22.58	-	-
EV/EBIT Ratio	48.25	45.62	-	-	-
EV/FCF Ratio	71.77	-	-	-
Debt / Equity Ratio	0.61	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	3.40	4.00	9.21	3.63	2.30
Debt / FCF Ratio	-	16.10	-	-	-
Asset Turnover	-	0.55	0.52	0.57	-
Inventory Turnover	-	1.69	1.94	1.87	-
Quick Ratio	-	0.61	0.64	0.69	0.82
Current Ratio	-	1.25	1.26	1.34	1.47
Return on Equity (ROE)	-	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	-	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	3.24%	2.30%	-0.24%	3.60%	-
Return on Capital Employed (ROCE)	-	4.20%	-	5.70%	10.50%
Earnings Yield	0.13%	0.10%	-2.28%	-	-
FCF Yield	1.71%	-5.89%	-	-
Dividend Yield	0.05%	0.08%	-	-	-
Payout Ratio	0.00%	-	-	13.30%	-
Buyback Yield / Dilution	-8.30%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-8.25%	-7.76%	-0.95%	-87.83%	-

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.